| Financial Year |
March 31 2023 |
| Monetary Funds |
932,104,216.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
235,175,737.58 |
| Advances to Suppliers |
193,381,055.97 |
| Other Receivables |
185,565,305.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
558,867,778.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
65,022,881.53 |
| Other Current Assets |
79,014,587.02 |
| Total Current Assets |
2,671,088,153.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
424,995,269.55 |
| Investment Properties |
-- |
| Fixed Assetes |
3,506,959,943.75 |
| Under-construction Projects |
981,633,476.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,507,943.41 |
| R&D expenses |
-- |
| Goodwill |
589,376,627.22 |
| Long-Term Deferred and Prepaid Expenses |
9,187,033.70 |
| Deferred Income Tax Assets |
75,469,383.10 |
| Other Non-Current Assets |
108,083,984.90 |
| Sub-Total of Non-Current Assets |
6,045,800,278.10 |
| Total Assets |
8,716,888,431.19 |
| Short-Term Loans |
1,121,787,269.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
592,697,103.07 |
| Accounts Payable |
645,209,035.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,546,374.32 |
| Taxes Payable |
15,124,712.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,398,538.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
493,611,552.15 |
| Other Current Liabilities |
2,381,704.02 |
| Sub-Total of Current Liabilities |
3,127,553,293.18 |
| Long-term Loans |
1,162,791,371.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,626,582.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,344,527.98 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,213,044,550.11 |
| Total Liabilities |
4,340,597,843.29 |
| Paid-In Capital(Or Share Stock) |
865,000,000.00 |
| Capital Surplus |
1,549,669,844.18 |
| Surplus Reserve |
285,861,570.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,312,543,754.96 |
| Minority Stockholder's Interest |
362,618,929.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,013,671,658.30 |
| Owner's Equity（Stockholder's Equity） |
4,376,290,587.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,716,888,431.19 |
